BoobyBiome develops a probiotic supplement specifically designed for infants with compromised gut microbiomes, utilizing research on beneficial bacteria found in breast milk. This product addresses the health risks associated with low breastfeeding rates and underdeveloped microbiomes in infants, providing essential support for their digestive health.
Funding
$2.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Infants with underdeveloped gut microbiomes, often due to low breastfeeding rates or other factors, face increased health risks. These infants may lack the beneficial bacteria crucial for establishing a healthy digestive system and long-term well-being.
Solution
BoobyBiome develops probiotic supplements designed to deliver beneficial breast milk bacteria to infants, regardless of their access to breast milk. By translating cutting-edge breast milk microbiome research into accessible solutions, BoobyBiome aims to provide every baby with the essential microbial foundation for a healthy future. The company's products support the establishment of a robust gut microbiome, laying the groundwork for both short-term digestive health and long-term immune function. BoobyBiome collaborates with experts and institutions to enhance the scalability, accessibility, and health benefits of its products.
Target Audience
The primary target audience includes parents and families seeking to support their infant's gut health, particularly those with challenges related to breastfeeding or concerns about underdeveloped microbiomes.
Features
- Probiotic supplement containing beneficial bacteria sourced from breast milk
- Formulation designed to support the development of a healthy infant gut microbiome
- Products intended to address the challenges associated with low breastfeeding rates
- Collaboration with the Great Ormond Street Institute of Child Health